Adams, D. J., Gamscik, M. P., Colvin, O. M., Flowers, J. L., Chen, S., Hollister, B. A., … Pommier, Y. G. (2001). Peptidyl-camptothecins are effective topoisomerase I inhibitors and potent antitumor agents. CLINICAL CANCER RESEARCH, 7(11), 3795S-3795S.

Adams, D. J., M. P. Gamscik, O. M. Colvin, J. L. Flowers, S. Chen, B. A. Hollister, G. Manikumar, M. C. Wani, M. E. Wall, and Y. G. Pommier. “Peptidyl-camptothecins are effective topoisomerase I inhibitors and potent antitumor agents.” CLINICAL CANCER RESEARCH 7, no. 11 (November 1, 2001): 3795S-3795S.

Adams DJ, Gamscik MP, Colvin OM, Flowers JL, Chen S, Hollister BA, et al. Peptidyl-camptothecins are effective topoisomerase I inhibitors and potent antitumor agents. CLINICAL CANCER RESEARCH. 2001 Nov 1;7(11):3795S-3795S.

Adams, D. J., et al. “Peptidyl-camptothecins are effective topoisomerase I inhibitors and potent antitumor agents.” CLINICAL CANCER RESEARCH, vol. 7, no. 11, AMER ASSOC CANCER RESEARCH, Nov. 2001, pp. 3795S-3795S.

Adams DJ, Gamscik MP, Colvin OM, Flowers JL, Chen S, Hollister BA, Manikumar G, Wani MC, Wall ME, Pommier YG. Peptidyl-camptothecins are effective topoisomerase I inhibitors and potent antitumor agents. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2001 Nov 1;7(11):3795S-3795S.